T1DTechCHW: Community Health Workers and Type 1 Diabetes Technology — T1DTechCHW  

Diabetes Clinical Trial

Official title: T1DTechCHW: Enhancing the Community Health Worker (CHW) Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups (YA-URMs) With Type 1 Diabetes (T1D)

Status Not yet recruiting

Clinical Trial Summary

The objective of this application is to test the early effects and implementation of an enhanced community health worker (CHW) model (T1DTechCHW) that encourages and supports diabetes technology use in young adults from underrepresented minority groups (YA-URMs) with type 1 diabetes (T1D). The investigators will conduct a 6-month randomized controlled trial in which YA-URMs will be randomized to T1DTechCHW or usual care. The investigators will recruit from endocrinology and primary care practices in a large safety-net health system in the Bronx, New York. Our specific aims are to 1) evaluate T1DTechCHW effects on technology initiation and continued use over 6 months and 2) evaluate T1DTechCHW implementation using Proctor's Taxonomy of Implementation Outcomes: feasibility, adoption, fidelity, and cost.

Clinical Trial Description

The investigators propose a 6-month randomized control trial of usual care versus T1DTechCHW, an intervention that enhances core community health worker (CHW) service roles to support increased use of T1D technology in young adults (underrepresented minorities)(YA_URM's). Participants will be recruited from primary and specialty care practices at Montefiore Medical Center in the Bronx, NY, which is a large safety-net hospital system in one of the poorest counties in the U.S. A young adult-aged CHW from the Montefiore CHW program will be trained extensively per our (Supporting Emerging Adults with Diabetes) SEAD manuals to provide YA-URMs and providers with specialized support. For YA-URMs, CHWs will conduct hands-on diabetes technology education, goal-setting, peer support, and social service linkage. CHWs will also help shift insurance approval tasks away from busy providers and better align patient-provider priorities through close communication between the YA-URM and provider. Group sessions will be optional and will follow the YA-centric education curriculum developed in Dr. Agarwal's Supporting Emerging Adults with Diabetes (SEAD) program. ;

Related Conditions & MeSH terms

• Diabete Mellitus
• Diabetes
• Diabetes Mellitus
• Diabetes Mellitus, Type 1
• Type 1 Diabetes
• Young Adult

• NCT number: NCT05211869
• Study type: Interventional
• Source: Albert Einstein College of Medicine
• Contact: Shivani Agarwal, MD, MPH
• Phone: 917-576-6590
• Email: [email protected]
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 2022
• Completion date: March 2025